# CHRS (Coherus Oncology, Inc.) - SEC EDGAR Financial Statements

> Coherus Oncology, Inc. reported $53.64M in revenue and a net loss of $135.9M for the trailing twelve months ended September 30, 2026 (up 23.4% year over year), with a 69.8% gross margin and a -275.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/CHRS
- Markdown: https://convexityos.com/fundamentals/CHRS.md
- SEC CIK: 0001512762
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:49 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001512762&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $53.64M | +23.4% YoY |
| Operating Income | TTM | -$148.0M | -275.9% margin |
| Net Income | TTM | -$135.9M | -253.4% net margin |
| Diluted EPS | TTM | -$0.88 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $83.63M | Total debt: $1.95M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $42.17M | $26.39M | $257.2M | $211.0M | $326.6M | $475.8M | $356.1M | $0 | $1.56M | $190.1M |
| Cost of Revenue | $13.81M | $8.73M | $159.0M | $70.08M | $57.59M | $37.67M | $17.08M | -- | -- | -- |
| **Gross Profit** | $28.36M | $17.66M | $98.25M | $141.0M | $269.0M | $438.2M | $339.0M | -- | -- | -- |
| Research & Development | $108.9M | $91.83M | $109.4M | $199.4M | $363.1M | $142.8M | $94.19M | $110.2M | $162.4M | $254.4M |
| Selling, General & Admin | $100.6M | $125.5M | $192.0M | $198.5M | $169.7M | $139.1M | $137.0M | $94.18M | $71.30M | $51.60M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | $248.3M | $204.4M | $233.7M | $306.0M |
| **Operating Income** | -$181.1M | -$199.7M | -$203.2M | -$256.9M | -$263.9M | $156.3M | $107.8M | -$204.4M | -$232.1M | -$115.9M |
| **EBITDA** | -$179.8M | -$198.1M | -$200.0M | -$253.3M | -$260.4M | $159.2M | $111.0M | -$201.2M | -$228.7M | -$112.9M |
| Interest Income | $7.00M | $4.50M | $2.80M | $1.90M | $1.40M | $600K | $1.60M | $1.40M | -- | -- |
| Interest Expense | $9.00M | $10.73M | $40.54M | $32.47M | $22.96M | $21.17M | $17.60M | $9.68M | $9.55M | $7.98M |
| Income Before Tax | -$183.1M | -$215.4M | -$238.3M | -$291.8M | -$287.1M | $135.7M | $92.78M | -$209.4M | -$238.3M | -- |
| Income Tax Expense | $0 | $0 | -$380K | $0 | $0 | $3.46M | $2.94M | $0 | $0 | $0 |
| **Net Income** | $168.0M | $28.51M | -$237.9M | -$291.8M | -$287.1M | $132.2M | $89.83M | -$209.3M | -$238.2M | -$127.3M |
| Basic EPS | $1.43 | $0.25 | -$2.53 | -$3.76 | -$3.81 | $1.85 | $1.29 | -$3.22 | -$4.48 | -$3.04 |
| **Diluted EPS** | $1.43 | $0.25 | -$2.53 | -$3.76 | -$3.81 | $1.62 | $1.23 | -$3.22 | -$4.48 | -$3.04 |
| Basic Shares Outstanding | 117.1M | 114.6M | 94.2M | 77.6M | 75.4M | 71.4M | 69.7M | 65.0M | 53.1M | 41.9M |
| Diluted Shares Outstanding | 117.1M | 114.6M | 94.2M | 77.6M | 75.4M | 83.5M | 73.2M | 65.0M | 53.1M | 41.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $14.27M | $14.31M | $12.31M | $12.75M | $11.57M | $10.25M | $7.60M | $7.73M |
| Cost of Revenue | $4.09M | $4.24M | $3.81M | $4.04M | $3.72M | $3.40M | $2.65M | $2.75M |
| **Gross Profit** | $10.18M | $10.06M | $8.50M | $8.70M | $7.85M | $6.86M | $4.95M | $4.98M |
| Research & Development | $22.61M | $21.44M | $21.54M | $30.97M | $27.25M | $26.31M | $24.36M | $20.76M |
| Selling, General & Admin | $21.23M | $20.95M | $23.10M | $23.61M | $24.93M | $26.04M | $26.02M | $29.61M |
| **Operating Income** | -$33.65M | -$32.33M | -$36.15M | -$45.88M | -$44.33M | -$45.49M | -$45.44M | -$45.38M |
| **EBITDA** | -$32.80M | -$31.47M | -$35.27M | -$45.58M | -$44.03M | -$45.19M | -$45.03M | -$45.28M |
| Interest Expense | $2.78M | $2.32M | $2.19M | $2.25M | $2.33M | $2.28M | $2.15M | $1.91M |
| Income Before Tax | -$38.88M | -$33.35M | -$36.94M | -$46.35M | -$44.52M | -$44.86M | -$47.40M | -$46.09M |
| **Net Income** | -$39.33M | -$20.63M | -$38.33M | -$37.64M | -$35.53M | $297.8M | -$56.57M | -$50.70M |
| Basic EPS | -$0.25 | -$0.13 | -$0.28 | -- | -$0.31 | $2.57 | -$0.49 | -- |
| **Diluted EPS** | -$0.25 | -$0.13 | -$0.28 | -- | -$0.31 | $2.57 | $2.57 | -- |
| Basic Shares Outstanding | 155.0M | 154.8M | 136.4M | -- | 116.2M | 116.1M | 115.9M | -- |
| Diluted Shares Outstanding | 155.0M | 154.8M | 136.4M | -- | 116.2M | 116.1M | 116.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $88.88M | $126.0M | $102.9M | $63.55M | $417.2M | $541.2M | $177.7M | $72.36M | $126.9M | $124.9M |
| Short-Term Investments | $83.25M | -- | $14.86M | $128.1M | -- | -- | $0 | $0 | -- | -- |
| **Cash & Short-Term Investments** | $172.1M | $126.0M | $117.7M | $191.7M | $417.2M | $541.2M | $177.7M | $72.36M | $126.9M | $124.9M |
| Accounts Receivable, Net | $17.82M | $111.3M | $260.5M | $110.0M | $123.0M | $157.0M | $142.0M | $0 | -- | $1.86M |
| Inventory | $3.17M | $4.21M | $62.60M | $38.79M | $37.64M | $44.23M | $9.81M | $1.66M | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | $83K | $142K | $2.99M |
| **Total Current Assets** | $206.7M | $341.6M | $475.6M | $381.2M | $602.3M | $767.5M | $343.0M | $84.43M | $145.5M | $161.5M |
| Property, Plant & Equipment, Net | $1.34M | $2.58M | $5.12M | $8.75M | $7.81M | $10.11M | $5.84M | $6.66M | $12.77M | $10.77M |
| Goodwill | -- | -- | $943K | $943K | $900K | $943K | $943K | $943K | $943K | $943K |
| Intangible Assets | $20.00M | $24.79M | $71.67M | $5.93M | $3.56M | $2.62M | $2.62M | $2.62M | $2.62M | $2.62M |
| Other Non-Current Assets | $4.05M | $6.49M | $9.69M | $8.67M | $10.03M | $12.54M | $362K | $14K | $13K | $1.88M |
| **Total Non-Current Assets** | $51.64M | $107.0M | $154.0M | $99.61M | $77.01M | $74.17M | $65.92M | $15.03M | $17.13M | $17.00M |
| **Total Assets** | $258.3M | $448.5M | $629.6M | $480.8M | $679.3M | $841.6M | $408.9M | $99.47M | $162.6M | $178.5M |
| Accounts Payable | $9.91M | $28.46M | $35.22M | $11.53M | $16.16M | $15.20M | $25.98M | $15.29M | $15.48M | $19.71M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | -- | -- | $892K |
| Other Current Liabilities | -- | -- | -- | -- | -- | $3.86M | $2.20M | $419K | $341K | $259K |
| **Total Current Liabilities** | $140.4M | $283.0M | $331.8M | $138.7M | $165.3M | $145.7M | $115.0M | $33.26M | $28.39M | $56.38M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $73.66M | $0 | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | -- | $669K |
| Other Non-Current Liabilities | $19.89M | $29.33M | $12.56M | $3.47M | $750K | $1.05M | $0 | $1.65M | $2.07M | $1.83M |
| **Total Non-Current Liabilities** | $56.94M | $297.5M | $491.3M | $479.6M | $416.3M | $415.0M | $188.7M | $104.8M | $103.7M | $102.8M |
| **Total Liabilities** | $197.3M | $580.5M | $823.0M | $618.3M | $581.6M | $560.7M | $303.7M | $138.1M | $132.1M | $159.1M |
| **Total Debt (incl. Leases)** | $3.29M | $4.98M | $7.47M | $9.36M | $10.74M | $13.08M | $86.11M | $0 | -- | -- |
| Common Stock | $12K | $12K | $11K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $5.0K |
| Retained Earnings | -$1.38B | -$1.55B | -$1.58B | -$1.34B | -$1.05B | -$762.8M | -$895.0M | -$984.8M | -$775.5M | -$537.3M |
| Accumulated Other Comp. Income | -$195K | -$275K | -$248K | -$249K | -$270K | -$270K | -$558K | -$282K | -$750K | -$630K |
| **Total Stockholders' Equity** | $61.01M | -$132.0M | -$193.4M | -$137.4M | $97.73M | $281.0M | $105.2M | -$38.59M | $30.54M | $20.53M |
| Total Equity | $61.01M | -$132.0M | -$193.4M | -$137.4M | $97.73M | $281.0M | $105.2M | -$38.59M | $30.54M | $19.35M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $53.49M | $82.92M | $115.2M | $88.88M | $103.4M | $216.9M | $82.41M | $126.0M |
| Short-Term Investments | $30.14M | $22.38M | $51.81M | $83.25M | $88.31M | $20.74M | -- | -- |
| **Cash & Short-Term Investments** | $83.60M | $105.3M | $167.0M | $172.1M | $191.7M | $237.6M | $82.41M | $126.0M |
| Accounts Receivable, Net | $13.72M | $13.88M | $22.06M | $17.82M | $9.24M | $5.11M | $60.49M | $111.3M |
| Inventory | $4.82M | $5.67M | $4.83M | $3.17M | $2.05M | $4.51M | $3.52M | $4.21M |
| **Total Current Assets** | $114.1M | $133.8M | $206.0M | $206.7M | $461.0M | $380.2M | $310.2M | $341.6M |
| Property, Plant & Equipment, Net | $652K | $865K | $1.09M | $1.34M | $1.63M | $1.91M | $2.26M | $2.58M |
| Intangible Assets | $18.12M | $18.75M | $19.38M | $20.00M | $20.62M | $23.45M | $24.12M | $24.79M |
| Other Non-Current Assets | $2.61M | $3.12M | $3.59M | $4.05M | $4.45M | $5.04M | $5.66M | $6.49M |
| **Total Non-Current Assets** | $56.98M | $57.40M | $59.99M | $51.64M | $55.56M | $59.26M | $60.89M | $107.0M |
| **Total Assets** | $171.1M | $191.2M | $266.0M | $258.3M | $516.5M | $439.5M | $371.1M | $448.5M |
| Accounts Payable | $14.51M | $13.17M | $11.48M | $9.91M | $24.89M | $37.62M | $40.93M | $28.46M |
| **Total Current Liabilities** | $75.64M | $75.51M | $132.3M | $140.4M | $372.3M | $263.6M | $255.0M | $283.0M |
| Other Non-Current Liabilities | $17.67M | $17.59M | $16.97M | $19.89M | $17.55M | $16.73M | $31.29M | $29.33M |
| **Total Non-Current Liabilities** | $70.22M | $54.84M | $55.07M | $56.94M | $56.45M | $56.01M | $299.5M | $297.5M |
| **Total Liabilities** | $145.9M | $130.3M | $187.4M | $197.3M | $428.7M | $319.6M | $554.5M | $580.5M |
| **Total Debt (incl. Leases)** | $1.95M | $2.41M | -- | $3.29M | -- | -- | -- | $4.98M |
| Common Stock | $15K | $15K | $15K | $12K | $12K | $12K | $12K | $12K |
| Retained Earnings | -$1.48B | -$1.44B | -$1.42B | -$1.38B | -$1.35B | -$1.31B | -$1.61B | -$1.55B |
| Accumulated Other Comp. Income | -$287K | -$281K | -$268K | -$195K | -$203K | -$275K | -$275K | -$275K |
| **Total Stockholders' Equity** | $25.25M | $60.84M | $78.62M | $61.01M | $87.77M | $119.8M | -$183.5M | -$132.0M |
| Total Equity | $25.25M | $60.84M | $78.62M | $61.01M | $87.77M | $119.8M | -$183.5M | -$132.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $168.0M | $28.51M | -$237.9M | -$291.8M | -$287.1M | $132.2M | $89.83M | -$209.4M | -$238.3M | -$127.8M |
| Depreciation & Amortization | $1.30M | $1.60M | $3.20M | $3.60M | $3.50M | $2.89M | $3.26M | $3.23M | $3.40M | $3.00M |
| Stock-Based Compensation | $16.97M | $27.80M | $43.11M | $50.74M | $51.36M | $38.16M | $33.59M | $34.80M | $33.40M | $27.42M |
| Change in Receivables | $93.56M | $149.3M | -$150.7M | $13.05M | $34.06M | -$15.22M | -$142.0M | $0 | $1.86M | -$299K |
| Change in Inventory | -$17.11M | -$31.95M | -$46.73M | -$47.35M | -$6.25M | -$38.36M | -$48.58M | -$5.48M | $0 | -- |
| Change in Payables | -$19.56M | -$3.94M | $23.76M | -$4.55M | $874K | -$9.82M | $9.89M | -$301K | -$3.81M | -$4.96M |
| **Operating Cash Flow** | -$138.5M | -$20.44M | -$174.9M | -$241.1M | -$37.43M | $154.1M | $28.36M | -$159.3M | -$200.3M | -$252.5M |
| Capital Expenditure | -- | -- | -$286K | -$2.04M | -$1.29M | -$7.23M | -$1.82M | -$789K | -$4.57M | -$6.51M |
| **Free Cash Flow** | -- | -- | -$175.2M | -$243.2M | -$38.72M | $146.9M | $26.53M | -$160.1M | -$204.9M | -$259.1M |
| Purchases of Investments | -$103.8M | -- | -$19.51M | -$127.4M | -$182.5M | -$273.8M | -$20.23M | -$42.87M | -$74.34M | -- |
| **Investing Cash Flow** | $375.1M | $230.3M | $144.6M | -$166.8M | -$138.4M | -$14.40M | -$12.73M | -$1.19M | -$4.42M | -$6.51M |
| Common Stock Issued | -- | $1.46M | -- | -- | $40.90M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | -$273.7M | -$187.0M | $69.60M | $54.33M | $51.88M | $223.9M | $89.37M | $105.4M | $206.8M | $226.2M |
| **Net Change in Cash** | -$37.13M | $22.91M | $39.36M | -$353.6M | -$124.0M | $363.7M | $104.7M | -$54.56M | $1.96M | -$33.28M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$39.33M | -$20.63M | -$38.33M | -$37.64M | -$35.53M | $297.8M | -$56.57M | -$50.70M |
| Depreciation & Amortization | $853K | $862K | $881K | $300K | $300K | $300K | $400K | $100K |
| Stock-Based Compensation | $3.68M | $2.58M | $2.38M | $2.78M | $3.39M | $5.42M | $5.37M | $6.38M |
| Change in Receivables | $161K | $8.22M | -$4.28M | -$8.34M | -$4.27M | $55.27M | $50.89M | $56.33M |
| Change in Inventory | -$67K | $437K | -$11.31M | -$1.11M | $2.48M | $3.77M | -$22.24M | -$6.45M |
| Change in Payables | $734K | $1.69M | $2.56M | -$5.09M | -$15.30M | -$12.21M | $13.04M | $6.34M |
| **Operating Cash Flow** | -$34.02M | -$62.09M | -$57.89M | -$19.72M | -$46.34M | -$46.63M | -$25.83M | $28.61M |
| Purchases of Investments | -$30.06M | -$13.90M | -$6.39M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$7.61M | $29.63M | $30.66M | -$2.84M | -$67.23M | $462.6M | -$17.49M | -$542K |
| Common Stock Issued | $0 | $0 | $53.65M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $12.05M | $144K | $53.59M | $8.08M | $2.0K | -$281.5M | -$264K | $231K |
| **Net Change in Cash** | -$29.58M | -$32.31M | $26.36M | -$14.47M | -$113.6M | $134.5M | -$43.58M | $28.30M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 67.2% | 66.9% | 38.2% | 66.8% | 82.4% | 92.1% | 95.2% | -- | -- | -- |
| **Operating Margin** | -429.5% | -756.6% | -79.0% | -121.7% | -80.8% | 32.9% | 30.3% | -- | -14918.8% | -61.0% |
| **Net Profit Margin** | 398.4% | 108.0% | -92.5% | -138.2% | -87.9% | 27.8% | 25.2% | -- | -15306.6% | -67.0% |
| Return on Equity (ROE) | 275.4% | -- | -- | -- | -293.8% | 47.1% | 85.4% | -- | -780.0% | -620.3% |
| Return on Assets (ROA) | 65.0% | 6.4% | -37.8% | -60.7% | -42.3% | 15.7% | 22.0% | -210.5% | -146.5% | -71.3% |
| Current Ratio | 1.47x | 1.21x | 1.43x | 2.75x | 3.64x | 5.27x | 2.98x | 2.54x | 5.12x | 2.86x |
| Quick Ratio | 1.45x | 1.19x | 1.24x | 2.47x | 3.42x | 4.97x | 2.90x | 2.49x | 4.47x | 2.25x |
| Debt to Equity | 0.05x | -- | -- | -- | 0.11x | 0.05x | 0.82x | -- | -- | -- |
| **Revenue Growth (YoY)** | +59.8% | -89.7% | +21.9% | -35.4% | -31.4% | +33.6% | -- | -100.0% | -99.2% | +532.8% |
| Gross Profit Growth (YoY) | +60.6% | -82.0% | -30.3% | -47.6% | -38.6% | +29.3% | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -268.8% | +45.1% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | +489.4% | -- | -- | -- | -317.1% | +47.2% | -- | -- | -- | -- |
| EPS Growth (YoY) | +472.0% | -- | -- | -- | -305.9% | +43.4% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -124.3% | +443.6% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -126.4% | +453.7% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -94.6% | -95.5% | -- | +9183.2% | -4.6% | +723.4% | +40.0% | -100.0% | -92.3% | -- |
| 10Y Revenue / Share Growth | -55.5% | -93.7% | +379.5% | +610.6% | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -22.5% | -80.7% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 69.8% | 68.9% | 68.1% | 67.2% | 66.3% | 63.6% | 68.6% | 66.9% |
| **Operating Margin** | -275.9% | -311.6% | -366.6% | -429.5% | -486.1% | -578.9% | -559.7% | -756.6% |
| **Net Profit Margin** | -253.4% | -259.4% | 397.3% | 398.4% | 417.1% | 568.1% | -413.3% | 108.0% |
| Return on Equity (ROE) | -538.4% | -217.2% | 236.9% | 275.4% | 176.6% | 150.0% | -- | -- |
| Return on Assets (ROA) | -79.4% | -69.1% | 70.0% | 65.0% | 30.0% | 40.9% | -35.3% | 6.4% |
| Current Ratio | 1.51x | 1.77x | 1.56x | 1.47x | 1.24x | 1.44x | 1.22x | 1.21x |
| Quick Ratio | 1.45x | 1.70x | 1.52x | 1.45x | 1.23x | 1.43x | 1.20x | 1.19x |
| Debt to Equity | 0.08x | 0.04x | -- | 0.05x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | +23.4% | +39.5% | +62.0% | +64.9% | +91.2% | -0.4% | +229.2% | -91.6% |
| Gross Profit Growth (YoY) | +29.7% | +46.7% | +71.8% | +74.7% | +136.2% | -19.2% | +469.2% | -28.4% |
| **Net Income Growth (YoY)** | -- | -106.9% | -- | -- | -- | -- | -155.0% | -- |
| EPS Growth (YoY) | -- | -105.1% | -- | -- | -- | -- | -153.8% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -168.9% | -- | -178.1% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
